CHRNA7 and atherosclerosis: Ulleryd et al. demonstrated that activation of α7nAChRs with a selective α7nAChRs agonist decreases atherosclerosis in ApoE−/− mice with suppression of pro-inflammatory cytokines as a possible athero-protective mechanism [51].